Form 4: Prothena Corp Director Lars Ekman Acquires Stock Options
SEC Form 4 Filing
Director Lars Ekman reports acquisition of stock options in Prothena Corp Public Ltd Co.
Summary
- Lars Ekman, a director of Prothena Corp Public Ltd Co, reported a transaction on May 14, 2025.
- Ekman acquired 20,183 stock options with an exercise price of $6.885.
- These options vest on the earlier of the first anniversary of the grant date or the day of the annual general meeting in 2026, assuming continuous service as a director.
- The options expire on May 14, 2035.
- Following the transaction, Ekman directly owns 20,183 derivative securities.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a standard disclosure of stock option acquisition by a director, which is neither particularly positive nor negative on its own.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates a director's increased stake in the company, which can be viewed positively by investors.
Stakeholder Impact
- The acquisition of stock options by a director can signal confidence in the company's future performance to shareholders.
Key Dates
| Date | Description |
|---|---|
| 05/14/2025 | Date of transaction: Lars Ekman acquired stock options. |
| 05/14/2026 | Earliest vesting date for the stock options, contingent on continuous service. |
| 05/14/2035 | Expiration date of the stock options. |
Keywords
stock options, director, Prothena Corp, Lars Ekman, Form 4, beneficial ownership, securities
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.